Altisource Portfolio Solutions美股招股说明书(2025-12-03版)

This prospectus relates to the resale by the investors listed in the section of this prospectus entitled “Selling Stockholders” (the“Selling Stockholders”) of up to 7,224,028 (the “Shares”) shares of our common stock, US$0.01 par value per share (“commonstock”). We issued the Shares to the Selling Stockholders pursuant to that certain Exchange Agreement, dated February19, 2025, We are registering the Shares covered by this prospectus as required by a registration rights agreement by and among theCompany and the Selling Stockholders, dated February19, 2025 (the “Registration Rights Agreement”). Our registration of the Shares covered by this prospectus does not mean that the Selling Stockholders will offer or sell any of theShares pursuant to this prospectus. The Selling Stockholders may sell the Shares covered by this prospectus in a number of differentways and at varying prices. For additional information on the possible methods of sale that the Selling Stockholders may use, you No underwriter or other person has been engaged to facilitate the sale of the Securities in this offering. The Selling Stockholdersmay be deemed to be “underwriters” within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), of theShares that they are offering pursuant to this prospectus. We will bear all costs, expenses and fees in connection with the registration of You should read this prospectus, any applicable prospectus supplement and any related free writing prospectus carefully before Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties describedunder the heading “Risk Factors” on page5 of this prospectus, the applicable prospectus supplement and in any applicable free Our common stock is currently listed on the Nasdaq Global Select Market under the symbol “ASPS.” On November 26, 2025, thelast reported sale price of our common stock was $9.30 per share. Our stock price is subject to fluctuation. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved ofthese securities, or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminaloffense. The date of this prospectus is November 28, 2025. TABLE OF CONTENTS ABOUT THIS PROSPECTUSINDUSTRY AND MARKET DATASUMMARY ABOUT THIS PROSPECTUS You should rely only on the information we have provided or incorporated by reference into this prospectus, any applicableprospectus supplement and any related free writing prospectus. We have not authorized anyone to provide you with informationdifferent from that contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. Nodealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus, anyapplicable prospectus supplement or any related free writing prospectus. You must not rely on any unauthorized information orrepresentation. This prospectus is an offer to sell only the Shares offered hereby, but only under circumstances and in jurisdictions The Selling Stockholders are offering the Shares only in jurisdictions where such issuances are permitted. The distribution of thisprospectus and the issuance of the Shares in certain jurisdictions may be restricted by law. Persons outside the United States who comeinto possession of this prospectus must inform themselves about, and observe any restrictions relating to, the issuance of the Shares This prospectus describes the terms of the offering of the Shares by the Selling Stockholders. If required, each time the SellingStockholders offer shares of common stock, we will provide you with, in addition to this prospectus, a prospectus supplement that willcontain specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to beprovided to you that may contain material information relating to that offering. We may also use a prospectus supplement and anyrelated free writing prospectus to add, update or change any of the information contained in this prospectus or in documents we haveincorporated by reference. This prospectus, together with any applicable prospectus supplements, any related free writing prospectusesand the documents incorporated by reference into this prospectus, includes all material information relating to this offering. To the When we refer to “Altisource,” “we,” “our,” “us” and the “Company” in this prospectus we mean Altisource Portfolio SolutionsS.A., a Luxembourg société anonyme, or public limited liability company, and its consolidated subsidiaries, unless the context This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference ismade to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual docum